Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19088921 | 0.93 | RIPK1 (0.36) | RIPK1TAS1R3TAS1R1PDE4DPDE4A | |
| SCHEMBL17426939 | 0.92 | RIPK1 (0.34) | RIPK1TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL17898764 | 0.90 | RIPK1 (0.33) | RIPK1 | |
| SCHEMBL17427116 | 0.89 | ITGA4 (0.36) | MEN1KMT2ATAS1R3TAS1R1 | |
| SCHEMBL19084210 | 0.89 | TAS1R3 (0.38) | RIPK1TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL17427151 | 0.89 | RIPK1 (0.35) | RIPK1MEN1CYP1A2KMT2APDE4D | |
| SCHEMBL19088924 | 0.88 | PDE4D (0.36) | RIPK1PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL19628447 | 0.87 | MERTK (0.36) | MEN1CYP1A2KMT2ATAS1R3TAS1R1 | |
| SCHEMBL17427098 | 0.87 | RIPK1 (0.35) | RIPK1PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL17898828 | 0.87 | RIPK1 (0.34) | RIPK1TAS1R3TAS1R1PDE4DPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170273303-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | CORTEVA AGRISCIENCE LLC | 2017-09-28 | — | — | US | disclosed |
| US-20170273303-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | CORTEVA AGRISCIENCE LLC | 2017-09-28 | — | — | US | disclosed |
| US-20170273303-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | CORTEVA AGRISCIENCE LLC | 2017-09-28 | — | — | US | disclosed |
| US-9686984-B2 | Macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2017-06-27 | — | — | US | disclosed |
| US-9686984-B2 | Macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2017-06-27 | — | — | US | disclosed |
| US-9686984-B2 | Macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2017-06-27 | — | — | US | disclosed |
| US-20160007602-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC | 2016-01-14 | — | — | US | disclosed |
| US-20160007602-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC | 2016-01-14 | — | — | US | disclosed |
| US-20160007602-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC | 2016-01-14 | — | — | US | disclosed |
| WO-2016007531-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2016-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170273303-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | CYP4F12, CYP1A2, FKBP2 | RIPK1 4127/4885MEN1 1512/4885CYP1A2 2/4885 |
| US-20160007602-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | CYP4F12, CYP1A2, FKBP2 | RIPK1 4127/4885MEN1 1512/4885CYP1A2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.